Dissection of the Endogenous Cellular Pathways of PCSK9-induced Low Density Lipoprotein Receptor Degradation

This publication has 39 references indexed in Scilit:

• A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates
  Proceedings of the National Academy of Sciences, 2009
• Antagonism of Secreted PCSK9 Increases Low Density Lipoprotein Receptor Expression in HepG2 Cells
  Journal of Biological Chemistry, 2009
• Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptor
  Proceedings of the National Academy of Sciences, 2008
• Molecular basis for LDL receptor recognition by PCSK9
  Proceedings of the National Academy of Sciences, 2008
• Clathrin light chains function in mannose phosphate receptor trafficking via regulation of actin assembly
  Proceedings of the National Academy of Sciences, 2008
• The Cellular Trafficking of the Secretory Proprotein Convertase PCSK9 and Its Dependence on the LDLR
  Traffic, 2007
• Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9
  Proceedings of the National Academy of Sciences, 2005
• Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype
  Proceedings of the National Academy of Sciences, 2004
• Mutations in PCSK9 cause autosomal dominant hypercholesterolemia
  Nature Genetics, 2003
• The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiation
  Proceedings of the National Academy of Sciences, 2003